Genentech offers the BioOncology Co-pay Assistance Program to help qualified, commercially insured patients with the out-of-pocket costs associated with their Tarceva prescription. Eligible patients can pay $5 for their Tarceva co-pay.
Full Answer
How do I pay for my Genentech medicine?
If you are concerned about paying for your Genentech medicine, please call our Patient Resource Center at (877) 436-3683. Ready to Enroll? Fill out the Patient Consent Form and send it to Genentech Access Solutions to get started. The form can be submitted in any of these 3 ways: We are here to help.
How do I enroll in Genentech access solutions?
If you are concerned about paying for your Genentech medicine, please call our Patient Resource Center at (877) 436-3683. Ready to Enroll? Fill out the Patient Consent Form and send it to Genentech Access Solutions to get started. The form can be submitted in any of these 3 ways:
What is Tarceva Genetech BioOncology co-pay card?
Tarceva Genetech BioOncology Co-pay Card: Eligible patients may pay $5 copay per prescription and receive an annual savings of up to $25,000 per year; for additional information contact the program at 855-692-6729.
What are patient assistance programs for Tarceva?
Patient Assistance Programs for Tarceva. Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines.
See more
What is Tarceva approved for?
Tarceva is prescribed for patients with metastatic non-small cell lung cancer (NSCLC) whose cancer has been identified to have certain Epidermal Growth Factor Receptor (EGFR) mutations by an FDA-approved test (first-line treatment).
What is the Genentech Patient Foundation?
The Genentech Patient Foundation gives free medicine to people who have financial concerns, because we believe that every person who is prescribed a Genentech medicine should get the treatment they need. Help for People With or Without Health Insurance. Call (866) 4ACCESS/(866) 422-2377.
Is Tarceva still used for lung cancer?
Tarceva is prescribed for patients with non-small cell lung cancer (NSCLC) whose cancer has spread to other parts of the body and that has certain types of epidermal growth factor receptor (EGFR) mutations.
Is Tagrisso better than Tarceva?
Tagrisso improved overall survival duration compared to Tarceva and Iressa. Median overall survival was 38.6 months compared to 31.8 months with first generation EGFR-TKIs. More than half (54%) of Tagrisso treated patients were alive at three years compared to 44% for Tarceva or Iressa.
What drugs does Genentech make?
Our Medicines & ProductsMedicines.Actemra® (TOCILIZUMAB [authorized for Emergency Use])Actemra® (tocilizumab)Activase® (alteplase)Alecensa® (alectinib)Avastin® (bevacizumab)Boniva Tablets® (ibandronate sodium)Cathflo Activase® (alteplase)More items...
How much is erlotinib cost?
The cost for erlotinib oral tablet 25 mg is around $1,388 for a supply of 30 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Can erlotinib cure lung cancer?
Erlotinib at the standard oral daily dose of 150mg is approved for the treatment of unselected chemorefractory advanced non-small cell lung cancer patients as well as maintenance therapy after first-line chemotherapy.
Does Tarceva shrink tumors?
Most patients respond to Tarceva, their tumors shrinking or even becoming undetectable. However, this effect is temporary. Most tumors come back, and most of them are 'equipped' with a new mutation in EGFR, known as T790M.
How long do people live on Tagrisso?
The median overall survival was 38.6 months for TAGRISSO vs 31.8 months for erlotinib or gefitinib.
How long can you survive Tagrisso?
Tagrisso showed a 52% reduction in risk of central nervous system disease progression or deathTagrisso (n=279)Survival at 12 months (95% CI)89.1% (84.8-92.2)Survival at 24 months (95% CI)74.2% (68.6-79.0)Survival at 36 months (95% CI)53.7% (47.5-59.5)CNS PFS (secondary endpoint)i,123 more rows•Sep 30, 2019
Can EGFR mutation be reversed?
Is there a cure for EGFR-positive NSCLC? Early-stage EGFR-mutant NSCLC can potentially be cured with surgery or radiation therapy, either with or without chemotherapy.
What is Genentech famous?
Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
Who acquired Genentech?
Roche Holding'sRoche Holding's agreement on Thursday to acquire full ownership of Genentech for $46.8 billion is the third big drug industry merger this year.
Where is Genentech headquarters?
South San Francisco, CAGenentech / HeadquartersGenentech's corporate headquarters are in South San Francisco, California (37.657°N 122.379°W), with additional manufacturing facilities in Vacaville, California; Oceanside, California; and Hillsboro, Oregon.
Who started Genentech?
Robert A. SwansonHerbert BoyerGenentech/Founders
How to contact Tarceva?
Get answers to your questions about prescribing Tarceva. SUPPORT. Medicine Information Support. Medical information about Genentech medicines. Call us at (800) 821-8590, Monday-Friday, 5am-5pm PT. Request a Call Back.
How many Tarceva patients have ILD?
Cases of serious ILD, including fatal cases, can occur with Tarceva treatment. The overall incidence of ILD in approximately 32,000 Tarceva-treated patients in uncontrolled studies and studies with concurrent chemotherapy was approximately 1.1%. In patients with ILD, the onset of symptoms was between 5 days to more than 9 months (median 39 days) after initiating Tarceva therapy.
What is the incidence of hepatic failure in the 3 monotherapy lung cancer studies?
In clinical studies where patients with moderate to severe hepatic impairment were excluded, the pooled incidence of hepatic failure in the 3 monotherapy lung cancer studies was 0.4% in the Tarceva arms and 0% in the control arms. The incidence of hepatic failure in the pancreatic cancer study was 0.4% in the Tarceva plus gemcitabine arm and 0.4% in the control arm.
How long after Tarceva is given to use contraception?
Advise females of reproductive potential to use effective contraception during therapy and for one month after the last dose of Tarceva.
What is the liver test for Tarceva?
Perform periodic liver testing (transaminases, bilirubin, and alkaline phosphatase) during treatment with Tarceva. Increased frequency of monitoring of liver function is required for patients with pre-existing hepatic impairment or biliary obstruction.
What is the number for Genentech?
Genentech Patient Resource Center. Our center dedicated to getting patients and caregivers to the right resources. Call us at (877) 436-3683 or (877) GENENTECH, Monday-Friday, 6am-5pm PT. Genentech Access Solutions. This service offers your patients coverage support, assistance, and other useful information.
Can you take Tarceva if you have a cough?
If ILD is confirmed, permanently discontinue Tarceva.
What is the number to call Genentech?from genentech-access.com
Getting your prescribed medicines should not be one of them. If you are concerned about paying for your Genentech medicine, please call our Patient Resource Center at (877) 436-3683.
How to contact Genentech about compassionate use?from gene.com
If you are seeking information about access to one of Genentech's investigational medicines, please call Genentech's Clinical Trial Information Support Line at (888) 662-6728 or Genentech's Compassionate Use Information Line at (844) ...
What is GSF patient library?from geneticsupportfoundation.org
GSF has a Patient Library that provides more background information on a variety of topics in genetics, including a genetics overview (Genetics 101), Genetics & Pregnancy, and Genetics & Cancer, among others. Learn more.
Does Genentech support evrysdi?from gene.com
Please Note: At this time, Genentech supports Evrysdi, Nutropin, Cellcept, Valcyte, and Fuzeon through a separate process.
Apply For Help
If you are a health care provider, click below to learn how to apply online or via fax.
Health Care Providers
Health Care Providers can submit the completed Patient Consent and Prescriber Foundation form in two ways:
Patients
Step 1: Complete the online Patient Consent Form, which is available in English and Spanish: Patient Consent Form | Formulario de Consentimiento del Paciente
Who provides Genentech medicine?
The Genentech Patient Foundation provides free Genentech medicine to people who don't have insurance coverage or who have financial concerns and to people who meet certain income criteria.*
Does Tecentriq refer to Genentech?
If eligible commercially insured patients need assistance with their out-of-pocket costs, TECENTRIQ Access Solutions can refer them to the Genentech Oncology Co-pay Assistance Program. *
Supporting People Who Need Help Paying For Our Medicines
Genentech has always focused on developing breakthrough medicines for serious illnesses. We believe every person should get the Genentech medicine they need, and we offer programs to help make this happen.
Learn How We Help
Explains insurance coverage to people taking Genentech medicines and connects them to support programs.
How much does Genentech add to a household?
For households larger than 4 people, add $25,000 for each extra person. There is no maximum number of people you may add. The Genentech Patient Foundation assists patients living in the United States, who are being treated by a physician licensed in the United States.
Why is Genentech patient foundation important?
People can have trouble getting their medicines for many reasons. The Genentech Patient Foundation helps people in need, whether they have insurance or not.
Have you been prescribed a participating Genentech medicine?
If one of these situations applies to you, you may qualify for support from the Genentech Patient Foundation. Please complete the enrollment forms to apply for help.
What is Tarceva used for?
Tarceva (erlotinib) is a member of the EGFR inhibitors drug class and is commonly used for Non-Small Cell Lung Cancer, and Pancreatic Cancer.
How much does a free drug card save?
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
